These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15470040)

  • 1. Essential role of LFA-1 in activating Th2-like responses by alpha-galactosylceramide-activated NKT cells.
    Matsumoto G; Kubota E; Omi Y; Lee U; Penninger JM
    J Immunol; 2004 Oct; 173(8):4976-84. PubMed ID: 15470040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
    Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
    J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
    J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of alpha-galactosylceramide-activated Valpha14 natural killer T cells in the regulation of Th2 cell differentiation.
    Nakayama T; Yamashita M; Kawano T; Shimizu C; Shibata Y; Kamata T; Kaneko Y; Kobayashi S; Takeda U; Motohashi S; Cui J; Taniguchi M
    Int Arch Allergy Immunol; 2001; 124(1-3):38-42. PubMed ID: 11306921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.
    Kitamura H; Iwakabe K; Yahata T; Nishimura S; Ohta A; Ohmi Y; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nishimura T
    J Exp Med; 1999 Apr; 189(7):1121-8. PubMed ID: 10190903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells.
    Leite-De-Moraes MC; Hameg A; Pacilio M; Koezuka Y; Taniguchi M; Van Kaer L; Schneider E; Dy M; Herbelin A
    J Immunol; 2001 Jan; 166(2):945-51. PubMed ID: 11145671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
    Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
    Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells.
    Cui J; Watanabe N; Kawano T; Yamashita M; Kamata T; Shimizu C; Kimura M; Shimizu E; Koike J; Koseki H; Tanaka Y; Taniguchi M; Nakayama T
    J Exp Med; 1999 Sep; 190(6):783-92. PubMed ID: 10499917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-18 time-dependently modulates Th1/Th2 cytokine production by ligand-activated NKT cells.
    Uchida T; Kinoshita M; Fukasawa M; Habu Y; Shinomiya N; Seki S
    Eur J Immunol; 2007 Apr; 37(4):966-77. PubMed ID: 17330820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of alpha-galactosylceramide-activated Valpha14 natural killer T cells in the regulation of allergic diseases.
    Iwamura C; Nakayama T
    Allergol Int; 2007 Mar; 56(1):1-6. PubMed ID: 17259803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation.
    Harada M; Seino K; Wakao H; Sakata S; Ishizuka Y; Ito T; Kojo S; Nakayama T; Taniguchi M
    Int Immunol; 2004 Feb; 16(2):241-7. PubMed ID: 14734609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner.
    Coppieters K; Van Beneden K; Jacques P; Dewint P; Vervloet A; Vander Cruyssen B; Van Calenbergh S; Chen G; Franck RW; Verbruggen G; Deforce D; Matthys P; Tsuji M; Rottiers P; Elewaut D
    J Immunol; 2007 Aug; 179(4):2300-9. PubMed ID: 17675491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation by Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 of alpha-galactosylceramide-induced antimetastatic activity and Th1 and Th2 responses of NKT cells.
    Okajo J; Kaneko Y; Murata Y; Tomizawa T; Okuzawa C; Saito Y; Kaneko Y; Ishikawa-Sekigami T; Okazawa H; Ohnishi H; Matozaki T; Nojima Y
    J Immunol; 2007 May; 178(10):6164-72. PubMed ID: 17475843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans.
    Kawakami K; Kinjo Y; Yara S; Koguchi Y; Uezu K; Nakayama T; Taniguchi M; Saito A
    Infect Immun; 2001 Jan; 69(1):213-20. PubMed ID: 11119508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.
    Ikarashi Y; Iizuka A; Heike Y; Yoshida M; Takaue Y; Wakasugi H
    Immunol Lett; 2005 Nov; 101(2):160-7. PubMed ID: 16054231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer T cells from interleukin-4-deficient mice are defective in early interferon-gamma production in response to alpha-galactosylceramide.
    Togashi Y; Chamoto K; Wakita D; Tsutsumi N; Iwakura Y; Matsubara N; Kitamura H; Nishimura T
    Cancer Sci; 2007 May; 98(5):721-5. PubMed ID: 17359285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.
    Fujii S; Shimizu K; Kronenberg M; Steinman RM
    Nat Immunol; 2002 Sep; 3(9):867-74. PubMed ID: 12154358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for IFN-gamma in IL-12 production induced by collaboration between v(alpha)14(+) NKT cells and antigen-presenting cells.
    Yang YF; Tomura M; Ono S; Hamaoka T; Fujiwara H
    Int Immunol; 2000 Dec; 12(12):1669-75. PubMed ID: 11099306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
    Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
    Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.